Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biora

This article was originally published in The Gray Sheet

Executive Summary

Plans to launch its PrefGel in the third quarter of 1998 following recent FDA clearance, the company says June 3. PrefGel, which is to be used by periodontists for conditioning exposed root surfaces during periodontal surgery, received European approval under the name PrepHgel earlier this year. PrefGel is the company's second dental therapy to reach the market. Its first product, Emdogain, for treatment of intrabony defects, was approved in 1996 ("The Gray Sheet" Oct. 21, 1996, I&W-4)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010138

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel